share_log

Adverum Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(9.9%),TCG Crossover Fund II, L.P.(9.9%), etc.

Adverum Biotechnologies | SC 13G:超過5%持股股東披露文件-TCG Crossover GP II, LLC(9.9%),TCG Crossover Fund II, L.P.(9.9%)等

SEC announcement ·  02/15 16:23
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息